Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint Dive into the research topics of 'Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy'. Together they form a unique fingerprint.

Medicine & Life Sciences